Velocity Clinical Research — Grand Island, Nebraska

Velocity Clinical Research is a clinical research site located in Grand Island, Nebraska, United States 68803.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research has participated in 7 clinical trials with 2 currently active.

Therapeutic areas: COVID-19, Genital Herpes, Chikungunya Virus Infection.

Sponsors: Novavax, ModernaTX, Inc., Valneva Austria GmbH.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research?

Velocity Clinical Research has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research conducted?

Velocity Clinical Research has 7 clinical trials on record, with 2 currently active. Their work covers COVID-19, Genital Herpes, Chikungunya Virus Infection.

Is Velocity Clinical Research accredited by Crixeo Health?

Velocity Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Velocity Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.